Anti-inhibitor coagulant complex Intravenous and Kisqali (200 MG Dose)
Determining the interaction of Anti-inhibitor coagulant complex Intravenous and Kisqali (200 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: anti-inhibitor coagulant complex
Brand name: Feiba, Feiba VH Immuno, Autoplex T, Feiba NF
Synonyms: Anti-inhibitor coagulant complex, Anti-inhibitor Coagulant Complex (Human)
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Anti-inhibitor coagulant complex Intravenous-Kisqali (400 MG Dose)
- Anti-inhibitor coagulant complex Intravenous-Kisqali (600 MG Dose)
- Anti-inhibitor coagulant complex Intravenous-Kisqali Femara Co-Pack
- Anti-inhibitor coagulant complex Intravenous-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Anti-inhibitor coagulant complex Intravenous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Anti-inhibitor coagulant complex Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Kisqali (200 MG Dose)-Anti-Itch (Diphenhydramine (Topical))
- Kisqali (200 MG Dose)-Anti-Itch Maximum Strength
- Kisqali (200 MG Dose)-Anti-thymocyte globulin rabbit
- Kisqali (200 MG Dose)-Antibiotic Cream Topical
- Kisqali (200 MG Dose)-Antibiotic Otic
- Kisqali (200 MG Dose)-Antibiotic Plus Pain Relief